Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 6 mg showed no clear difference in endoscopic improvement compared with placebo (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.96 [0.73, 1.27]
2 studies · 440 participants
Moderate

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg probably leads to higher endoscopic improvement compared with placebo (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.29 [1.01, 1.66]
2 studies · 442 participants
Moderate

Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in endoscopic improvement compared with entocort EC 9mg (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.14 [0.82, 1.6]
1 study · 212 participants
Moderate